Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Buchholz TJ"'
Autor:
Walter, Peter, Kampmann, Martin, Acosta-Alvear, D, Cho, MY, Wild, T, Buchholz, TJ, Lerner, AG, Simakova, O, Hahn, J, Korde, N, Landgren, O, Maric, I
Publikováno v:
Walter, Peter; Kampmann, Martin; Acosta-Alvear, D; Cho, MY; Wild, T; Buchholz, TJ; et al.(2015). Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6hg5t112
© 2015 eLife Sciences Publications Ltd. All rights reserved.Hallmarks of cancer, including rapid growth and aneuploidy, can result in non-oncogene addiction to the proteostasis network that can be exploited clinically. The defining example is the ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::b6c736b82c1b66277e23a3324e610896
http://www.escholarship.org/uc/item/6hg5t112
http://www.escholarship.org/uc/item/6hg5t112
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carpio C; Department of Hematology, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona, Barcelona, Spain., Bouabdallah R; Institut Paoli-Calmettes, Marseille, France., Ysebaert L; Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Sancho JM; Catalan Institute of Oncology (ICO)-Josep Carreras Leukaemia Research Institute (IJC)-Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Salles G; Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Cordoba R; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Pinto A; Istituto Nazionale Tumori, Fondazione G. Pascale, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Napoli, Italy., Gharibo M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Rasco D; South Texas Accelerated Research Therapeutics LLC, San Antonio, TX., Panizo C; Clinica Universidad de Navarra, Pamplona, Spain., Lopez-Martin JA; 12 de Octubre University Hospital & Research Institute, Grupo Español de Terapias Inmuno-Biológicas en Cáncer (GÉTICA), Madrid, Spain., Santoro A; Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy., Salar A; Hospital del Mar, Barcelona, Spain., Damian S; Fondazione IRCCS, Milan, Italy., Martin A; Hospital Universitario de Salamanca and Instituto de Investigación Biomedica de Salamanca (IBSAL), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain., Verhoef G; UZ Gasthuisberg Leuven, Leuven, Belgium., Van den Neste E; Cliniques Universitaires Saint-Luc, Université de Louvain, Brussels, Belgium., Wang M; Bristol-Myers Squibb, San Diego, CA., Couto S; Genmab Pharmaceuticals, Princeton, NJ., Carrancio S; Bristol-Myers Squibb, San Diego, CA., Weng A; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada., Wang X; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada., Schmitz F; Fred Hutchinson Cancer Research Center, Seattle, WA., Wei X; Bristol-Myers Squibb, Berkeley Heights, NJ., Hege K; Bristol-Myers Squibb, San Francisco, CA., Trotter MWB; Celgene Institute for Translational Research Europe, A Bristol-Myers Squibb Company, Seville, Spain., Risueño A; Celgene Institute for Translational Research Europe, A Bristol-Myers Squibb Company, Seville, Spain., Buchholz TJ; Bristol-Myers Squibb, San Francisco, CA., Hagner PR; Bristol-Myers Squibb, Summit, NJ; and., Gandhi AK; Bristol-Myers Squibb, Summit, NJ; and., Pourdehnad M; Bristol-Myers Squibb, San Francisco, CA., Ribrag V; Institut Gustave Roussy, Villejuif, France.
Publikováno v:
Blood [Blood] 2020 Mar 26; Vol. 135 (13), pp. 996-1007.
Autor:
Winter MB; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States., La Greca F; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States., Arastu-Kapur S; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States.; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, San Francisco, United States., Caiazza F; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States., Cimermancic P; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States., Buchholz TJ; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, San Francisco, United States., Anderl JL; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, San Francisco, United States., Ravalin M; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States., Bohn MF; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States., Sali A; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States.; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States., O'Donoghue AJ; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, San Diego, United States., Craik CS; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States.
Publikováno v:
ELife [Elife] 2017 Nov 28; Vol. 6. Date of Electronic Publication: 2017 Nov 28.
Autor:
Mishto M; Institut für Biochemie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Centro Interdipartimentale di Ricerca sul Cancro 'Giorgio Prodi', Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy. Electronic address: michele.mishto@charite.de., Raza ML; Institut für Neurophysiology, Charité - Universitätsmedizin Berlin, Garystr. 5, 14195 Berlin, Germany., de Biase D; Dept. of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy., Ravizza T; Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via Giuseppe La Masa 19, 20156 Milan, Italy., Vasuri F; Institute of Oncology and Transplant Pathology at Department of Experimental, Diagnostic and Specialty Medicine, DIMES, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy., Martucci M; Dept. of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy., Keller C; Institut für Biochemie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Bellavista E; Dept. of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy., Buchholz TJ; Onyx Pharmaceuticals Inc., Amgen Subsidiary, 249 E. Grand Ave., South San Francisco, CA 94080, USA., Kloetzel PM; Institut für Biochemie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Pession A; Department of Pharmacy and Biotechnology, FaBiT, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy., Vezzani A; Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via Giuseppe La Masa 19, 20156 Milan, Italy., Heinemann U; Institut für Neurophysiology, Charité - Universitätsmedizin Berlin, Garystr. 5, 14195 Berlin, Germany.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2015 Oct; Vol. 49, pp. 188-96. Date of Electronic Publication: 2015 Jun 01.
Autor:
Acosta-Alvear D; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, San Francisco, United States., Cho MY; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Wild T; The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark., Buchholz TJ; Onyx Pharmaceuticals, Inc. an Amgen subsidiary, South San Francisco, United States., Lerner AG; Onyx Pharmaceuticals, Inc. an Amgen subsidiary, South San Francisco, United States., Simakova O; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, United States., Hahn J; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, United States., Korde N; Multiple Myeloma Section, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, United States.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States., Landgren O; Multiple Myeloma Section, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, United States.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States., Maric I; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, United States., Choudhary C; The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark., Walter P; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, San Francisco, United States., Weissman JS; Howard Hughes Medical Institute, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Kampmann M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, San Francisco, United States.
Publikováno v:
ELife [Elife] 2015 Sep 01; Vol. 4, pp. e08153. Date of Electronic Publication: 2015 Sep 01.
Autor:
Rauch JN; Department of Biological Chemistry, ‡Department of Chemistry, and the§ Life Sciences Institute, University of Michigan , Ann Arbor, Michigan 48109, United States., Nie J, Buchholz TJ, Gestwicki JE, Kennedy RT
Publikováno v:
Analytical chemistry [Anal Chem] 2013 Oct 15; Vol. 85 (20), pp. 9824-31. Date of Electronic Publication: 2013 Sep 23.
Autor:
Chemler JA; Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, USA., Buchholz TJ, Geders TW, Akey DL, Rath CM, Chlipala GE, Smith JL, Sherman DH
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2012 May 02; Vol. 134 (17), pp. 7359-66. Date of Electronic Publication: 2012 Apr 23.
Autor:
Buchholz TJ; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA., Rath CM, Lopanik NB, Gardner NP, Håkansson K, Sherman DH
Publikováno v:
Chemistry & biology [Chem Biol] 2010 Oct 29; Vol. 17 (10), pp. 1092-100.
Autor:
Buchholz TJ; Life Sciences Institute, Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA., Geders TW, Bartley FE 3rd, Reynolds KA, Smith JL, Sherman DH
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2009 Jan 16; Vol. 4 (1), pp. 41-52.